Metabolic Myopathy Mutation Profiles
| Mutation Profile | Mutation |
Frequency of Mutant Alleles (%) |
Exercise Intolerance (8 mutations) ▪ Myophosphorylase Deficiency ▪ Myoadenylate Deaminase Deficiency |
S113L Q12X, P48L |
60 60-80 |
| Exercise Intolerance + Expanded CPT2 Mutation Analysis | Full profile plus R503C & R631C mutations in CPT2 gene | |
| Carnitine Palmitoyltransferase II Deficiency | S113L |
60 |
| Myophosphorylase Deficiency | R50X G205S |
60-80 10 |
| Myoadenylate Deaminase Deficiency | Q12X,
P48L |
95 |
Prerequisites for any Metabolic Myopathy Mutation Profiles
Clinical: Patient should have evidence of pain, cramps or stiffness with exertion ± myoglobinuria. Non-metabolic causes should be ruled out. A clinical summary must accompany all specimens sent for analysis.
Laboratory: Laboratory-based evidence for a metabolic myopathy should exist which may include but not be limited to elevated serum creatine kinase, an abnormal ischemic exercise test result, and/or an abnormal EMG. A summary of prior laboratory test results, including a histopathology report, must accompany all specimens sent for analysis.
Consent: An informed consent for DNA testing and HIPPA form must be signed by the patient and accompany the specimen.
Specimen Requirements for molecular testing: 5 mL whole blood in EDTA, shipped to arrive within 24h of collection by overnight carrier at room temperature; 50 mgs skeletal muscle biopsy snap frozen in liquid nitrogen and stored at -70ºC until shipment on dry ice by overnight carrier.
Web Design By: RLComputing Phone: (716) 859-7741 | Fax: (716) 859-7749
